COMP <GO>
ALIT vs OPRX // RETURN ON INVESTED CAPITAL (ROIC)
Alight Inc. (Class A) (NYSE) VS. OptimizeRx Corporation (NASDAQ) • 15-METRIC TALLY: ALIT 1
— OPRX 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: OPRX
LAST: $9.17 (+1.44%) • MKT CAP: $247.0M
roic
-35.00%
LAST: $9.37 (+0.75%) • MKT CAP: $176.5M
roic
7.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALIT VS. OPRX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALIT | OPRX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.80% | 67.30% | -33.50 | OPRX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 7.30% | -42.30 | OPRX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 14.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 10.57% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 10.70% | -70.70 | OPRX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 4.70% | -64.70 | OPRX | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 18.80% | -21.80 | OPRX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 2.68 | -2.48 | OPRX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | OPRX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.1 | 63.6 | -20.44 | OPRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 28.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $247.0M | $176.5M | $70.5M | ALIT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALIT REV | OPRX REV | ALIT GROSS % | OPRX GROSS % | ALIT FCF | OPRX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.26B | $109.4M | 33.8% | 67.3% | $250.0M | $18.7M |
| FY 2024 | $2.33B | $92.1M | 34.0% | 64.5% | $131.0M | $4.8M |
| FY 2023 | $2.39B | $71.5M | — | — | $386.0M | -$7.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALIT // BETA —
OPRX // BETA —